|
positive regulation of double-strand break repair via nonhomologous end joining
|
GO_2001034 |
[Any process that activates or increases the frequency, rate or extent of double-strand break repair via nonhomologous end joining.] |
|
regulation of double-strand break repair via nonhomologous end joining
|
GO_2001032 |
[Any process that modulates the frequency, rate or extent of double-strand break repair via nonhomologous end joining.] |
|
negative regulation of double-strand break repair via nonhomologous end joining
|
GO_2001033 |
[Any process that stops, prevents or reduces the frequency, rate or extent of double-strand break repair via nonhomologous end joining.] |
|
GO_0042319
|
GO_0042319 |
|
|
obsolete positive regulation of cellular glucuronidation
|
GO_2001031 |
[OBSOLETE. Any process that activates or increases the frequency, rate or extent of cellular glucuronidation.] |
|
obsolete cell part morphogenesis
|
GO_0032990 |
[OBSOLETE. The process in which the anatomical structures of a cell part are generated and organized.] |
|
regulation of cellular response to drug
|
GO_2001038 |
[Any process that modulates the frequency, rate or extent of cellular response to drug.] |
|
positive regulation of tongue muscle cell differentiation
|
GO_2001037 |
[Any process that activates or increases the frequency, rate or extent of tongue muscle cell differentiation.] |
|
regulation of tongue muscle cell differentiation
|
GO_2001035 |
[Any process that modulates the frequency, rate or extent of tongue muscle cell differentiation.] |
|
obsolete cytosol nonspecific dipeptidase activity
|
GO_0042315 |
[OBSOLETE. Catalysis of the hydrolysis of dipeptides, preferentially hydrophobic dipeptides including prolyl amino acids.] |
|
negative regulation of tongue muscle cell differentiation
|
GO_2001036 |
[Any process that stops, prevents or reduces the frequency, rate or extent of tongue muscle cell differentiation.] |
|
protein kinase C deactivation
|
GO_0042313 |
[Any process resulting in the inhibition or termination of the activity of protein kinase C.] |
|
obsolete negative regulation of cellular glucuronidation
|
GO_2001030 |
[OBSOLETE. Any process that stops, prevents or reduces the frequency, rate or extent of cellular glucuronidation.] |
|
GO_0042312
|
GO_0042312 |
|
|
Bcl3-Bcl10 complex
|
GO_0032996 |
[A protein complex containing Bcl3 and Bcl10, which forms when Akt1 is activated by TNF-alpha to phosphorylate Bcl10; the Bcl3-Bcl10 complex is translocated to the nucleus.] |
|
Fc-alpha receptor I complex
|
GO_0032999 |
[A protein complex composed of an Fc-alpha R alpha chain and an Fc-epsilon RI gamma chain dimer with or without additional signaling components. The complex functions primarily as an activating receptor for IgA.] |
|
negative regulation of cellular response to drug
|
GO_2001039 |
[Any process that stops, prevents or reduces the frequency, rate or extent of cellular response to drug.] |
|
Fc-epsilon receptor I complex
|
GO_0032998 |
[A protein complex composed of an Fc-epsilon RI alpha chain and an Fc-epsilon RI gamma chain dimer with or without an Fc-episilon RI beta chain and additional signaling components. The complex functions primarily as an activating receptor for IgE.] |
|
negative regulation of integrin-mediated signaling pathway
|
GO_2001045 |
[Any process that stops, prevents or reduces the frequency, rate or extent of integrin-mediated signaling pathway.] |
|
regulation of integrin-mediated signaling pathway
|
GO_2001044 |
[Any process that modulates the frequency, rate or extent of integrin-mediated signaling pathway.] |